Amy Jones

Researcher

University of Arkansas for Medical Sciences

faculty

6 h-index 28 pubs 195 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Amy Jones's research focuses on the treatment of cervical intraepithelial neoplasia (CIN) and related human papillomavirus (HPV) infections. She has investigated the efficacy of a peptide-based therapeutic vaccine, PepCan, in combination with a Candida adjuvant, in clinical trials. Her work has explored the impact of these interventions on CIN2/3 lesions. Jones also has an interest in medical education, as indicated by her publication assessing changes in training for palliative medicine specialty. Her scholarship metrics include an h-index of 6, with 28 total publications and 195 citations. She has collaborated with researchers Charles M. Quick, David W. Ussery, Michael Scott Robeson, and William W. Greenfield at the University of Arkansas for Medical Sciences, with whom she shares multiple publications.

Metrics

  • h-index: 6
  • Publications: 28
  • Citations: 195

Selected Publications

  • A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
  • A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics